Episode 431: IMPACT Series - Axel Bex on Impactful RCC Clinical Trials

By The Uromigos - Last Updated: July 17, 2025

Axel Bex, MD, PhD,  joins the show to discuss trials that he thinks have impacted RCC. We also discuss consolidative approaches, neoadjuvant trials, and what can impact an academic career.

Post Tags:Uromigos-Kidney Cancer
Advertisement
Advertisement